Loading…
Loading…
This fund typically commits a minimum of 80% of its total capital to the constituent securities of its underlying index, or to depositary receipts representing those index holdings. The benchmark index is crafted to monitor the financial performance of companies that derive a significant portion of their business and revenue from the healthcare technology sector. These enterprises are selected for their robust potential for expansion within this field, driven by pioneering innovation and the successful market integration of their products and services. It is important to note that the fund operates on a non-diversified basis.
Is HTEC's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
As access to powerful general-purpose AI models expands, access alone offers limited differentiation. In precision healthcare, competitive advantage can come from combining proprietary clinical data, specialized models, and integration into diagnostic workflows.
.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.
ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC - Get Free Report) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 55,432 shares, an increase of 2,310.1% from the September 15th total of 2,300 shares. Currently, 3.1% of the shares of the stock
It's always exciting to see a fund perform well over the course of a month, but it's also important to understand exactly why that strong performance may be happening. Key Takeaways: September proved to be a relatively difficult month for many sectors of the equity market, including the healthcare sector.
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).